trending Market Intelligence /marketintelligence/en/news-insights/trending/smoKsKR-hucwHQ-_00-t6Q2 content esgSubNav
In This List

China Regenerative Medicine to invest $75M in healthcare fund

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Latin American and Caribbean Market Considerations Blog Series: Focus on LGD

BLOG

Banking Essentials Newsletter: June Edition


China Regenerative Medicine to invest $75M in healthcare fund

China Regenerative Medicine International Ltd. plans to invest $75 million in a healthcare fund via a subsidiary.

China Regenerative Medicine Ltd. entered into a commitment letter with Haitong International New Energy IX Ltd. to invest the amounts and become a limited partner of the fund.

The investment commitment is still subject to negotiations and signing of a definitive agreement.

China Regenerative expects that the transaction will help provide the company investment opportunities in innovative healthcare and healthcare-related business.

Haitong New Energy is a wholly owned subsidiary of Haitong International Securities Group Ltd.